Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade.

Jinglan Wang1, Max Harry Weil, Wanchun Tang

  • 1Institute of Critical Care Medicine, 35100 Bob Hope Drive, Rancho Mirage, CA 92270, USA. weilm@911research.org

The Journal of Laboratory and Clinical Medicine
|September 1, 2005
PubMed
Summary

Propranolol aids cardiac resuscitation and survival. Adding levosimendan further enhances myocardial contractile function post-resuscitation, improving outcomes after cardiac arrest.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A charge transfer highway for directed electron migration and local enrichment in Co@ZnIn<sub>2</sub>S<sub>4</sub>/UiO-66 toward ultraefficient hydrogen evolution.

Journal of colloid and interface science·2026
Same author

Efficacy of vibration therapy on physical function, activity and participation in people with stroke: a systematic review and meta-analysis of randomized controlled trials.

Journal of neuroengineering and rehabilitation·2026
Same author

Bionic Solar-Powered Heavy Metal Trap for Eco-Friendly Sludge Drying and Simultaneous Electricity Generation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Genetic variability and intra-genotype recombination of DuCV from ducks and geese in central and north China.

Frontiers in veterinary science·2026
Same author

Quantifying 808 nm Laser Penetration in Live Mouse Brain: A Comparison of Photodiode and Fiber Probe Methods for Transcranial Photobiomodulation Dosimetry.

Lasers in surgery and medicine·2026
Same author

Efficacy and Tolerability of Non-Routine Gastric Residual Volume Monitoring in Mechanically Ventilated Adults Receiving Early Enteral Nutrition: A Randomised Controlled Non-Inferiority Trial.

Nursing in critical care·2026

Area of Science:

  • Cardiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Nonselective beta-adrenergic blockers like propranolol have shown benefits in cardiac resuscitation.
  • Propranolol's negative inotropic effects necessitate exploring alternative or adjunctive therapies.
  • Levosimendan, a non-beta-adrenergic inotropic agent, may mitigate propranolol's adverse effects.

Purpose of the Study:

  • To investigate the combined efficacy of propranolol and levosimendan in minimizing post-resuscitation myocardial dysfunction.
  • To evaluate if levosimendan improves myocardial contractile function when administered with propranolol after cardiac arrest.

Main Methods:

  • A porcine model of cardiac arrest induced by ventricular fibrillation was used (n=15).
  • Animals were divided into control, propranolol, and propranolol plus levosimendan groups.

Related Experiment Videos

  • Propranolol was administered during cardiac arrest; levosimendan was given post-resuscitation.
  • Main Results:

    • Propranolol reduced defibrillation requirements and post-resuscitation myocardial ectopy.
    • Propranolol improved post-resuscitation myocardial dysfunction.
    • Combination therapy with levosimendan demonstrated enhanced post-resuscitation myocardial contractile function compared to propranolol alone.

    Conclusions:

    • Propranolol is beneficial in cardiac arrest resuscitation, reducing defibrillation needs and improving myocardial function.
    • Adjunctive levosimendan therapy significantly enhances myocardial contractile function following resuscitation from cardiac arrest.
    • The combination of propranolol and levosimendan represents a promising strategy for improving outcomes after cardiac arrest.